EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Icariin Alleviates Nonalcoholic Fatty Liver Disease in Polycystic Ovary Syndrome by Improving Liver Fatty Acid Oxidation and Inhibiting Lipid Accumulation

Yang Hai, Ling Zuo, Meng Wang, Ruoyu Zhang, Munan Wang, Li Ren, Congwen Yang, Jianwei Wang

Molecules · 2023

DOI: 10.3390/molecules28020517 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2023. Verfasst von Yang Hai und 7 weiteren Autor:innen. Beteiligte Einrichtung: Traditional Chinese Medicine Key Laboratory in Chongqing for Prevention and Cure of Metabolic Diseases, Chongqing 400016, China. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease, Polycystic Ovary Syndrome. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

(1)

Background

Icariin is the main component of the Chinese herb Epimedium. A number of studies have shown that it alleviates abnormal lipid metabolism. However, it is not clear whether and how icariin can ameliorate hepatic steatosis with polycystic ovary syndrome (PCOS). This study was designed to explore the anti-hepatosteatosis effect of icariin in rats with polycystic ovary syndrome. (2)

Methods

Female Sprague Dawley(SD)rats were treated with a high-fat diet and letrozole for 21 days to make nonalcoholic fatty liver disease (NAFLD) in the polycystic ovary syndrome model. Then model rats were treated with icariin (by gavage, once daily) for 28 days. Serum hormones and biochemical variables were determined by ELISA or enzyme. RNA-sequence analysis was used to enrich related target pathways. Then, quantitative Real-time PCR (qRT-PCR) and Western blot were performed to verify target genes and proteins. (3)

Results

Icariin treatment reduced excess serum levels of Testosterone (T), Estradiol (E2), Luteinizing hormone (LH), Follicle-stimulating hormone (FSH), LH/FSH ratio, insulin, triglycerides (TG), and aspartate aminotransferase (AST) in high-fat diet (HFD) and letrozole fed rats. Meanwhile, icariin ameliorated HFD and letrozole-induced fatty liver, as evidenced by a reduction in excess triglyceride accumulation, vacuolization, and Oil Red O staining area in the liver of model rats. Results of RNA-sequencing, western blotting, and qRT-PCR analyses indicated that icariin up-regulated fatty acid translocase (CD36), in mitochondria, and peroxisome proliferator-activated receptor α (PPARα) expression, which led to the enhancement of fatty acid oxidation molecules, such as cytochrome P450, family 4, subfamily a, polypeptide 3 (CYP4A3), carnitine palmitoyltransferase 1 α (CPT1α), acyl-CoA oxidase 1 (ACOX1), medium-chain acyl-CoA dehydrogenase (MCAD), and long-chain acyl-CoA dehydrogenase (LCAD). Besides, icariin reduced lipid synthesis, which elicited stearoyl-Coenzyme A desaturase 1 (SCD1), fatty acid synthase (FASN), and acetyl-CoA (ACC). (4)

Conclusion

Icariin showed an ameliorative effect on hepatic steatosis induced by HFD and letrozole, which was associated with improved fatty acid oxidation and reduced lipid accumulation in the liver.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Non-alcoholic Fatty Liver DiseasePolycystic Ovary SyndromeFemaleHumansRatsAnimalsLetrozoleRats, Sprague-DawleyLiverLipid MetabolismDiet, High-FatTriglyceridesFatty AcidsFollicle Stimulating HormoneRNAFlavonoids

Stichwörter der Autor:innen

fatty acid oxidationicariinliver lipid depositionnonalcoholic fatty liver diseasepolycystic ovary syndrome

Substanzen

LetrozoleTriglyceridesFatty AcidsFollicle Stimulating HormoneRNAicariinFlavonoids

Autor:innen und Institutionen

  • Traditional Chinese Medicine Key Laboratory in Chongqing for Prevention and Cure of Metabolic Diseases, Chongqing 400016, China.
  • College of Basic Medicine, Chongqing Medical University, Chongqing 400016, China.
  • College of Traditional Chinese Medicine, Chongqing Medical University, Chongqing 400016, China.

Förderung

  • the National Natural Science Foundation of China

Zitieren

APA

Hai, Y., Zuo, L., Wang, M., Zhang, R., Wang, M., Ren, L., Yang, C., & Wang, J. (2023). Icariin Alleviates Nonalcoholic Fatty Liver Disease in Polycystic Ovary Syndrome by Improving Liver Fatty Acid Oxidation and Inhibiting Lipid Accumulation. Molecules. https://doi.org/10.3390/molecules28020517

Vancouver

Hai Y, Zuo L, Wang M, Zhang R, Wang M, Ren L, et al. Icariin Alleviates Nonalcoholic Fatty Liver Disease in Polycystic Ovary Syndrome by Improving Liver Fatty Acid Oxidation and Inhibiting Lipid Accumulation. Molecules. 2023. doi:10.3390/molecules28020517

BibTeX
@article{Hai2023,
  author = {Hai, Yang and Zuo, Ling and Wang, Meng and Zhang, Ruoyu and Wang, Munan and Ren, Li and Yang, Congwen and Wang, Jianwei},
  title = {Icariin Alleviates Nonalcoholic Fatty Liver Disease in Polycystic Ovary Syndrome by Improving Liver Fatty Acid Oxidation and Inhibiting Lipid Accumulation},
  journal = {Molecules},
  year = {2023},
  doi = {10.3390/molecules28020517}
}
Kostenlos starten →